Atlas Trials

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Clinical trial NCT02521077 · WITHDRAWN

Trial details

NCT number
NCT02521077
Sponsor
Midwestern Regional Medical Center
Status
WITHDRAWN
Phase
Phase 2
Study type
INTERVENTIONAL
Fatigue
Start date
2017-05-01
Primary completion
2019-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.